biosciences

Welcome to the 'biosciences' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'biosciences'.

Latest blogosphere posts tagged “biosciences”

• (RDEA) Ardea Biosciences Inc. Lowers Loss

  
  Stock Blog Hub — Authority: 461
  Ardea Biosciences Inc. ( RDEA ) reported third quarter net loss of $2.47 million, or 13 cents per share, which was significantly lower than the Zacks Consensus Estimate of 47 cents. The company reported a net loss of $14.2 million or 95 cents in the year-ago period. The lower loss was attributable to the higher ...
  7 hours ago

• Chromosomes dance and pair up on the nuclear membrane

  
  Science Blog - Science news straight from the source — Authority: 626
  Meiosis -- the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell -- is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
  1 day ago

• Ironwood Nabs $75M in Deal With Japanese Firm, Gloucester Drug Gets FDA Approval, Alnylam Branches Into Biomanufacturing Tech, & More Boston-Area Life Sciences News

  
  Xconomy — Authority: 710
  Roundup , Life Sciences , FDA Rebecca Zacks wrote: Several of New England’s life sciences firms had good news to report this week. —Ryan gave a run-down of the key insights to emerge from our Xconomy Forum on pharma innovation . Sirtris CEO Christoph Westphal, for example, offered insight into one of ...
  2 days ago

• Pulmatrix Pulls in $30.2M, GenArts Gobbles Up Wondertouch, BioVex Bags $30M, & More Boston-Area Deals News

  
  Xconomy — Authority: 710
  Roundup , deals , VC Rebecca Zacks wrote: Several of New England’s tech and life sciences firms got juicy deals the past week and a half. —Boston’s RunMyErrand, an online clearinghouse where busy people can find helpers for odd jobs, raised $1 million in a Series A venture financing round. The ...
  3 days ago

• Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston-Area Biotechs

  
  Xconomy — Authority: 710
  Life Sciences , Drug Development , biotechnology Ryan McBride wrote: Sanofi-Aventis (NYSE: SNY ) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why Boston-area biotech companies should want to form partnerships with the French drug giant. It was an ...
  4 days ago

• Aastrom to Initiate Second Phase Clinical Trial for Treatment of Severe Chronic Heart Failure

  
  Ann Arbor Biz News — Authority: 132
  Catheter-Based Delivery of CRCs by Cardiologists to Expand Company’s Ongoing Cardiovascular Program ANN ARBOR, Mich., Nov. 10, 2009 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of autologous cell products for the treatment of chronic cardiovascular diseases, today announced that ...
  4 days ago

• Helicos Takes Itself Off Block

  
  Xconomy — Authority: 710
  Biotech , Finances , Genomics Luke Timmerman wrote: Helicos Biosciences (NASDAQ: HLCS ) said today that it has decided to call off discussions that could lead to a sale of the company, because of its “improving standalone prospects and its current market valuation.” The Cambridge, MA-based company ...
  5 days ago

• Aastrom Biosciences Reports First Quarter Fiscal Year 2010 Financial Results

  
  Ann Arbor Biz News — Authority: 132
  Focus on Cardiovascular Regeneration Sets Foundation for Continued Clinical Progress ANN ARBOR, Mich., Nov. 6, 2009 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of autologous cell products for the treatment of chronic cardiovascular diseases, today reported financial results and ...
  1 week ago

• Build it Boldly, and Pharma Will Come—and More Wisdom from Boston’s Biotech and Pharma Elite at Xconomy Forum

  
  Xconomy — Authority: 710
  Life Sciences , innovation , Xconomy Forum Ryan McBride wrote: It was an inspiring afternoon yesterday at Xconomy’s latest event, “Pharma’s Bet on Boston Innovation,” in Cambridge, MA. Local industry pioneers such as Millennium CEO Deborah Dunsire and Sirtris CEO Christoph Westphal talked about ...
  1 week ago

• Video - Stealthy Nanoparticles Attack Cancer Cells (Technology Review)

  
  NanoTechBIZZ.com — Authority: 153
  Jeff Hrkach and Greg Troiano of BIND Biosciences explain how they make drug-delivering nanoparticles. (get the story…) Related items Stealthy Nanoparticles Attack Cancer Cells (Technology Review) Scientists say nanoparticles may help kill tumors (Reuters via Yahoo! News) Gold Nanoparticles Could Detect ...
  1 week ago

• Enlight Biosciences Forms Partnership with Abbott Labs

  
  Xconomy — Authority: 710
  Life Sciences , deals , pharma Ryan McBride wrote: There’s big news about Enlight Biosciences breaking here at the Xconomy Forum: Pharma’s Bet on Boston Innovation. Abbott Laboratories (NYSE: ABT ) has joined the consortium of big pharmas that are supporting Enlight, according to CEO David ...
  1 week ago

• Paper Finds Microdroplet PCR Enrichment Is Ideal Targeted Sequencing Solution For Large-Scale Population Studies

  
  Industry PR — Authority: 114
  LEXINGTON, MASSACHUSETTS, U.S.A. – November 2, 2009 – Data generated using microdroplet PCR technology as an enrichment method is particularly well suited for performing sequence-based association studies, according to a paper published today by researchers at the Scripps Translational Science Institute, the ...
  1 week ago

• UK’s Enigma Looks to San Diego, Life Gets Sweeter for Senomyx, Arena Says Obesity Drug Is Not “Wimpy,” & More San Diego Life Sciences News

  
  Xconomy — Authority: 710
  Roundup , Life Sciences , Genetic Sequencing Denise Gellene wrote: San Diego’s life sciences news picked up a bit last week amid fresh signs of the area’s growing prominence in the laboratory tools and diagnostics sectors. —Carlsbad, CA-based Helixis , a startup maker of genetic analysis ...
  2 weeks ago

• Creating a digital revolution in anatomical pathology

  
  From Edison's Desk — Authority: 115
  If you follow the world of pathology, you might have read recently about Omnyx’s new autofocusing patent.  In a nutshell, it is the essential piece of IP needed to digitize a world that for more than 125 years has relied on a microscope and glass slides.To read more about Omnyx and GE Healthcare’sjoint venture ...
  2 weeks ago

• Sequenom Settles Ibis Dispute

  
  Xconomy — Authority: 710
  Biotech , Legal , Diagnostics Luke Timmerman wrote: Sequenom, the San Diego-based maker of laboratory tools and diagnostics, said today in a regulatory filing it has agreed to accept a $1 million payment from Ibis Biosciences, a unit of Abbott Laboratories, to settle a patent infringement lawsuit. As ...
  2 weeks ago

• Why is Pharma Betting So Big on Innovation in Boston?

  
  Xconomy — Authority: 710
  Biotech , people , Life Sciences Luke Timmerman wrote: What type of drugs have the greatest potential to fill the void in Big Pharma company pipelines, as the industry barrels toward the well-documented patent expiration crisis of coming years? What are the best techniques pharma companies can use to ...
  2 weeks ago

• LX211 highlighted as potential disease modifying therapy for non...

  
  Science nature & education - science-nature.marc8.com — Authority: 154
  (Kureczka/Martin Associates) LX211 (LUVENIQ; oral voclosporin) may become the first approved oral treatment capable of modifying the course of uveitis, otherwise inevitably associated with severe vision loss or substantial morbidity from steroid use. Phase 2/3 trial results highlight LX211s ability to control ...
  2 weeks ago

• The Making of a Good Patent Related Press Release

  
  IPWatchdog.com | Patents & Patent Law — Authority: 601
  One of the most frustrating things I encounter when blogging is finding a really great story courtesy of a press release and then realizing that the press release provides so little useful information that it is impossible to write anything other than a puff piece, which I simply will not do.  From time to time ...
  3 weeks ago

• Sanford Barsky, M.D., University of Nevada School of Medicine and Nevada Cancer Institute faculty member publishes scientific paper in the journal Nature

  
  Science Blog - Science news straight from the source — Authority: 626
  RENO/LAS VEGAS, Nev. -- Sanford Barsky, M.D., who holds faculty positions at the University of Nevada School of Medicine as chair of the pathology department and Nevada Cancer Institute chief of pathology, is part of a team that has a paper on transgenic mouse mammary tumors with direct relevance to human breast ...
  3 weeks ago

• RainDance Extends Sequence Enrichment Solution Capabilities With Methyl-Seq and Ultra-Deep Resequencing Applications

  
  Industry PR — Authority: 114
  HONOLULU, HAWAII, U.S.A., October 22, 2009 — RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, announced today it will extend the capabilities of its Sequence Enrichment Solution by offering Methyl-Seq and Ultra-Deep ...
  3 weeks ago

Comments about biosciences